Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site Sort descending
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Site Sort descending Location Division Business Functional Area Date Posted
Labortechniker / QC Analyst I (m/w/d), Schaftenau, Tirol Schaftenau Austria Operations Innovative Medicines Quality Oct 24, 2024
QC Specialist II (m/w/d), Schaftenau&Kundl, Tirol Schaftenau Austria Operations Innovative Medicines Quality Oct 25, 2024
Labortechniker / QC Analyst II (m/w/d), Schaftenau, Tirol, Österreich Schaftenau Austria Operations Innovative Medicines Quality Oct 22, 2024
Tactical Planner (f/m/d) Schaftenau Austria Operations Innovative Medicines Technical Operations Sep 25, 2024
Regulatory Affairs CMC Associate Director Schaftenau Austria Development Innovative Medicines Research & Development Sep 30, 2024
Labortechniker / QC Analyst I (m/f/d) Kundl, Schaftenau Schaftenau Austria Operations Innovative Medicines Quality Oct 17, 2024
Automation Team Lead Schaftenau Austria Operations Innovative Medicines Technical Operations Oct 02, 2024
Automation Engineer Schaftenau Austria Operations Innovative Medicines Technical Operations Oct 02, 2024
Process Expert (m/f/d) Schaftenau Austria Operations Innovative Medicines Technical Operations Oct 02, 2024
Commissioning & Qualification Engineer Warehouse & Logistics (m/w/d) Schaftenau Austria Operations Innovative Medicines Technical Operations Oct 16, 2024
Maintenance Technician (Mechatronics) Schaftenau Austria Operations Innovative Medicines Technical Operations May 21, 2024
Maintenance Technician (Mechatronics) Schaftenau Austria Operations Innovative Medicines Technical Operations Sep 03, 2024
Tax Specialist (m/w/d) Schaftenau Austria Finance CTS Audit & Finance Jul 22, 2024
Schichtleiter II / Abteilungsleiter Schaftenau Austria Operations Innovative Medicines Technical Operations Aug 28, 2024
Maintenance Technician (Instrumentation) Schaftenau Austria Operations Innovative Medicines Technical Operations May 09, 2024
Senior Expert Engineering, Device Development Schaftenau Austria Development Innovative Medicines Research & Development Sep 03, 2024
Automatisierungstechniker (m/w/d) Schaftenau Austria Operations Innovative Medicines Technical Operations Jul 08, 2024
Automatisierungsingenieur (m/w/d) Schaftenau Austria Operations Innovative Medicines Technical Operations Jul 10, 2024
Techniker (d/w/m) Schaftenau Austria Operations Innovative Medicines Technical Operations Jul 12, 2024
Produktionsmitarbeiter (m/w/d), Schaftenau, Tirol, Austria Schaftenau Austria Operations Innovative Medicines Technical Operations Oct 18, 2024
Mechaniker - Abfüllung & Inspektion (m/w/d) Schaftenau Austria Operations Innovative Medicines Technical Operations Oct 18, 2024
Expert - Medical Device Testing Laboratory (m/f/d) Schaftenau Austria Development Innovative Medicines Research & Development Oct 21, 2024
Hire to Retire Services Specialist Selangor Malaysia People & Organization CTS Human Resources Aug 19, 2024
R2R Senior Specialist - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Aug 19, 2024
FRA Technical Accounting & Special Projects APMA Selangor Malaysia Operations CTS Audit & Finance Aug 22, 2024
Ethics, Risk & Compliance Manager Selangor Malaysia Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compl. Aug 22, 2024
Sr Specialist DDIT IM JP & APMA Soln Int Selangor Malaysia Operations CTS Technology Transformation Aug 22, 2024
Engagement Services Senior Expert (Japanese Speaker) Selangor Malaysia People & Organization CTS Human Resources Sep 04, 2024
Hire to Retire Services Expert Selangor Malaysia People & Organization CTS Human Resources Sep 05, 2024
Manufacturing Systems Expert Selangor Malaysia Operations Innovative Medicines Technical Operations Sep 05, 2024
Regional Sourcing Manager APAC-Indirect (Japanese Speaker) Selangor Malaysia Operations CTS Procurement Jul 22, 2024
Project Manager Selangor Malaysia Operations CTS Technology Transformation Sep 03, 2024
R2R Specialist - Inventory Selangor Malaysia Finance CTS Audit & Finance Jul 28, 2024
S2P Business Partner (Korean speaker) Selangor Malaysia Finance CTS Audit & Finance Sep 24, 2024
Treasury & Cash Management Team Lead Selangor Malaysia Finance CTS Audit & Finance Aug 12, 2024
Specialist QA Operations Selangor Malaysia Operations Innovative Medicines Quality Oct 24, 2024
Engagement Services Expert (Japanese speaker) Selangor Malaysia People & Organization CTS Human Resources Oct 22, 2024
Manager- Data Privacy Review and Remediation Selangor Malaysia Ethics Risk & Compliance Corporate Legal & Intellectual Property & Compl. Oct 14, 2024
Product Specialist Selangor Malaysia International Innovative Medicines Sales Oct 15, 2024
Senior Product Specialist Selangor Malaysia International Innovative Medicines Sales Oct 15, 2024
R2R Senior Specialist - Inventory Selangor Malaysia Finance CTS Audit & Finance Oct 02, 2024
R2R Senior Specialist - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Oct 08, 2024
Site Operations Lead Selangor Malaysia Operations CTS BD&L & Strategic Planning Oct 08, 2024
R2R Team Lead - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Oct 10, 2024
R2R Specialist - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Oct 15, 2024
P2P & T&E Business Partner (Japanese speaker) Selangor Malaysia Finance CTS Audit & Finance Jun 12, 2024
R2R Senior Specialist GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Jun 13, 2024
Hire to Retire Services Specialist Selangor Malaysia People & Organization CTS Human Resources May 19, 2024
P2P & T&E Specialist (Japanese speaker) Selangor Malaysia Finance CTS Audit & Finance Jun 05, 2024
Associate Director ERC Risk&Operations, Corporate Functions Selangor Malaysia Ethics Risk & Compliance Corporate Legal & Intellectual Property & Compl. Aug 29, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only